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Abstract
Stem cell therapy is a promising option for regenerative of injured or diseased tissues.
However, the extremely low survival and engraftment of transplanted cells and the
obviously inadequate recruitment and activation of the endogenous resident stem cells
are the major challenges for stem cell therapy. Fortunately, recent progresses show that
extracellular matrix (ECM) could not only act as a spatial and mechanical scaffold to
enhance cell viability but also provide a supportive niche for engraftment or accelerat‐
ing stem cell differentiation. These findings provide a new approach for increasing the
efficiency of stem cell therapy and may lead to substantial changes in cell administra‐
tion. In order to take a giant stride forward in stem cell therapy, we need to know much
more about how the ECM affects cell behaviours. In this chapter, we provide an overview
of the influence of ECM on regulating stem cell maintenance and differentiation. Moreover,
the enhancement of supportive microenvironment function of natural or synthetic ECMs
in stem cell therapy is discussed.
Keywords: extracellular matrix (ECM), stem cell therapy, microenvironment, growth
factor, regenerative medicine
1. Introduction
Stem cells reside within a specific extracellular microenvironment, which consists of a com‐
plex mixture of soluble and insoluble, short- and long-range signals [1]. Extracellular matrix
(ECM) to which stem cells adheres is one of the microenvironmental parameters regulated stem-
cell fates [2–4]. Once moving outside of their niche, stem cells will quickly lose their develop‐
mental potential, which limits the application of stem cell therapy [5]. Besides, mounting evidence
on stem cells and their niche indicates that transplanted stem cells are unable to survive and
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adapt at the site of administration where there is lack of functional vascular network to transport
blood, supply oxygen and nutrients, and remove metabolites [6].
Through enhancing cell retention and engraftment after transplantation, modulating stem cell
fate, and promoting functional vasculature formation, co-transplantation stem cells with
natural or synthetic ECM that mimic natural extracellular milieu could be a potentially
powerful tool to break the current bottleneck and maximize the effectiveness of stem cell
therapy [7–9]. These strategies provide considerable hope for the development of stem cell
therapy in degenerative diseases. This chapter will provide the insights into the interaction
between stem cells and ECM, as well as current knowledge and involvement of stem cell
therapy. Moreover, we will discuss the strategy of co-transplantation stem cells and ECM for
tissue regeneration with enhanced therapeutic efficacy.
2. Why extracellular matrix is necessary for stem cell therapy
With the capacity of self-renewal and differentiation, stem cells have shown promising
potential in regenerative medicine and tissue engineering. So far, stem cell transplantation
have been proposed as future therapies for degenerative diseases or injury, including Alz‐
heimer's disease [10], type 1 diabetes [11], Parkinson's disease [12], cardiac disease [13], muscle
damage [14] and many others [15–17]. However, some studies showed that stem cell therapy
only had modest improvement, which could be attributed to the fact that transplanted cells
were unable to survive and adapt in the diseased area. For instance, low cell retention and
engraftment and remarkably cell death after transplantation have been observed by using
bioluminescence imaging (BLI) [18].
Though it is not clear what signals and underlying pathways cause the acute donor cell death
following transplantation, increasing evidence suggests that that a supportive microenviron‐
ment is of crucial importance for stem cell survival, proliferation and differentiation [5,19]. For
this reason, the strategy to seed stem cells on biomaterials that mimic the biochemical and
biophysical properties of native niche could be a viable solution to the above mentioned
problems [20] and optimize functional recovery of injured tissue (Figure 1). For instance,
Matrigel, a product derived from the Engelbroth-Holm-Swarm (EHS) mouse sarcoma, is one
of the most commonly used plate-coating materials for stem cell culture in vitro and effectively
applied vehicles for transplanted stem cells [21]. Mounting evidence has demonstrated that
Matrigel could affect cell fate in a variety of dimensions [21,22]. However, Matrigel is a complex
with unknown variable matrices and numerous mixed growth factors, which makes it
impossible for us to get further insights into the interplay of stem cells and ECM. Besides,
another reason for safety concern is that Matrigel has been reported contaminated with Lactate
Dehydrogenase Elevating Virus [23]. To avoid these problems, artificially synthetic ECM with
both high purity and defined components in qualitative and quantitative measures for safe
application is strongly demanded [24,25]. Recently, developments in engineered ECM-based
microenvironments have gradually exhibited their ability for directing stem cell behaviours,
such as adhesion, proliferation, and differentiation [26].
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Figure 1. Extracellular matrix(ECM) is necessary for stem cell therapy. A form of apoptosis, called “anoikis”, will be
initiated once interactions between stem cells and ECM are cut off. Re-establish the connection between ECM and de‐
tached cells could increase cell viability and promote function recovery of injured tissue [4]. Reprinted by permission
of the publisher.
3. Influence of the extracellular matrix on stem cell behaviour
Extracellular matrix (ECM), acting in conjunction with the biophysical properties and bio‐
chemical extracellular stimuli, is critical to regulate stem cell maintenance and differentiation
[27,28]. It has been reported that a form of apoptosis, called “anoikis”, would be initiated when
interactions between stem cells and ECM were cut off [19]. Great effort has been made in an
attempt to detail the mechanisms, which provides some key information for cell–ECM
interplay. For example, recent study investigated changes of genes’ expression after cell
detachment by using PCR Array [2]. In that study, researchers found that adhesion molecules
expression had no significant difference between cultured human embryonic stem cell-derived
Figure 2. ECM and cell adhesion related gene-expression patterns of hESC-EC at different conditions. Expression of
more than 4-fold changes genes of hESC-ECs in Matrigel compared with hESC-ECs in PBS [4]. Reprinted by permis‐
sion of the publisher.
Extracellular Matrix Enhances Therapeutic Effects of Stem Cells in Regenerative Medicine
http://dx.doi.org/10.5772/62229
325
endothelial cells (hESC-ECs) and enzymatically dispersed hESC-ECs suspended in Matrigel.
However, a series of ECM and adhesion molecules-specific genes was considerably down-
regulated in hESC-EC suspended in PBS (Figure 2). These gene-expression data indicated that
adding ECM to detached cells could reverse genes down-regulation of ECM pathway, cell
adhesion molecules pathway, ECM and adhesion signalling.
3.1. Biochemical stimulus
The assignment of cell fate results from a response to sophisticated extracellular signals [29,30].
There is mounting evidence suggesting that ECM could deliver numerous soluble and
immobilized factors that play vital roles in making the fate choice between self-renewal and
lineage commitment [31]. Further insights and exquisite control of signals transported by ECM
could provide opportunities for enhancing the regenerative efficacy in both in vitro and in
vivo and further accelerating the translation of basic science to the clinical setting.
3.1.1. Release of soluble factors
The propagation of soluble signalling molecules controls a great variety of cellular responses,
including proliferation [32], polarity [33], migration [34], and differentiation [35]. It has been
Figure 3. Putative model outlining the controlled nitric oxide (NO)-releasing hydrogel enhances the therapeutic ef‐
fect of adipose derived-mesenchymal stem cells (ADSCs) for myocardial infarction. Encapsulation of ADSCs by
NO-releasing hydrogel prevented transplanted cells effusing from injection positions. NO molecule released from the
hydrogel catalyzed by β-galactosidase can facilitate angiogenic cytokines secretion of ADSCs, resulting in promoting
angiogenesis, ADSCs survival and cardiac function. β-gal, β-galactosidase [9]. Reprinted by permission of the publish‐
er.
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demonstrated that a specific interaction between cells and ECM is required for the ultimate
biological response of soluble molecules [29,36,37]. Interactions with ECM can affect the
responses of cell toward signalling messengers. For instance, insulin-triggered activation of
insulin receptor substrate (IRS) was intensely enhanced in cells cultured on basement mem‐
brane than on collagen I, whereas higher levels of tyrosine phosphorylation of the EGF receptor
and Erk was triggered by EGF in cell adhesion to collagen I [36].
In living systems, the coordinated effort among cells, growth factors and ECM is required for
the successful tissue regeneration. The ability of manipulating biological signals transduced
by ECM in a controlled and spatiotemporal manner that mimic the natural regenerative
process could provide specific control over the stem cell-based regenerative therapy [38]. The
potential therapeutic effect of a peptide-based ECM with the capacity of controlled release
nitric oxide (NO), NapFF-NO, was tested in a mouse model of myocardial infarction [9]. The
therapeutic effect of adipose-derived-mesenchymal stem cells (ADSCs) was elevated through
co-transplantation with NapFF-NO and on-demand NO release (Figure 3). Additionally, the
administration of growth factors within the context of the ECM niche could accentuate their
therapeutic effects for tissue repair [39]. It was reported that a recombinant fragment of
fibronectin (FN) could significantly enhance the regenerative effects of growth factors in
models of chronic wounds and bone defects [40].
3.1.2. Immobilized factors
Sustained release and improved local retention of regenerative factors, such as growth factors
and extracellular substances, are required during tissue regeneration [41]. However, these
molecules are suffering from rapid degradation, and therefore they will quickly lose their
functionality and clinical efficacy [42]. Additionally, there is evidence that cellular processes
are also affected by the interactions between cells and non-soluble constituents of the ECM
[43]. For these reasons, immobilization of signalling molecules or functional components to
ECM could be suitable for stabilizing these highly reactive molecules, increasing local
concentration of biochemical stimuli, and increasing the bioactivity of engineered ECM.
A growing number of studies have utilized short synthetic peptides to mimic the biological
properties of full-length growth factors and to substitute parent proteins [44,45]. For example,
insulin-like growth factor 1 (IGF-1) is considered as an essential biochemical stimulus in tissue
regeneration. The C domain of IGF-1 (IGF-1C), a 12 amino acids sequence, had already been
proved as the active region of IGF-1 [46]. IGF-1C has been used as substitute for IGF-1 and
applied into hydrogel biomaterials as biomimetic material for tissue engineering and regen‐
erative medicine. The proliferation, apoptosis resistance, and paracrine effects of ADSCs were
significantly enhanced after they were seeded on chitosan (CS) hydrogel with immobilization
of IGF-1C [47]. When co-transplanted ADSCs with CS-IGF-1C hydrogel into ischemic organ,
this biomimetic matrix could create a favourable microenvironment for the survival and
adaptation of transplanted cells and further promote functional and structural recovery of
injured organ (Figure 4).
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Figure 4. Schema of renoprotective effects of ADSCs and synthetic ECM (CS-IGF-1C hydrogel). When co-trans‐
planted into AKI model, CS-IGF-1C hydrogel could protect delivered ADSCs, facilitated their paracrine and anti-in‐
flammatory effects, and inhibit ECM synthesis in kidney, which result in enhanced angiogenesis, regeneration and
alleviated fibrosis after kidney injuries. Consequently, CS-IGF-1C hydrogel therapy leads to improved functional and
structural recovery of kidney [47]. Reprinted by permission of the publisher.
3.2. Physical interaction
Although it has commonly acknowledged that signals transduced by ECM could direct stem
cell fate, there is increasing evidence that physical properties of ECM could also make a great
impact on cell behaviours [48–50]. Some of these factors are proven to be of great influence,
but we still have a long way to go and a lot of work to do to establish a complete theory. For
example, in response to injury, the accumulation of ECM is excess and abnormal, which would
cause significant changes to the stiffness of ECM and ultimately lead to tissue fibrosis [51,52].
3.2.1. Stiffness and elasticity
To test the effect of different stiffness (EY) on cell behaviors, substrates with EY ranging from
<1 kPa to 30 kPa were synthesized [53]. The results showed that ECM stiffness has influence
on cell proliferation as well as cell differentiation. For instance, neural stem/progenitor cells
(NSPCs) could proliferated on substrates with EY <10 kPa. On soft substrates (<1 kPa), neuronal
differentiation was promoted; whereas, on relatively stiff substrates (>7 kPa), oligodendrocyte
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differentiation was favoured. This consequence indicated that matrix stiffness had effect on
lineage choice and differentiation. In light of previous data that stiffness was a regulator of
differentiation, Shih et al. further explore how matrix affects the osteogenic phenotype of MSCs
[54]. They found that the matrix rigidity promoted osteogenic commitment through a α2-
integrin-ROCK-FAK-ERK1/2 axis.
Fascinatingly, it was observed that mesenchymal stem cells all underwent osteogenic differ‐
entiation on both stiff and soft polydimethylsiloxane (PDMS) substrates; whereas, the osteo‐
blast differentiation of the same cells was promoted on stiff polyacrylamide (PAAm)
hydrogels, and more cell differentiated into adipocytes on soft PAAm hydrogels [55]. The
different cellular responses to different substrates indicated that stiffness was not an inde‐
pendent stimulus for differentiation. Further data provided in this study suggested that the
differentiation of human mesenchymal stem cells on PAAm was also regulated by the elastic
modulus. Consistent with the previous study, Xue et al. reported that matrix elasticity was the
main physical parameter directing stem cell differentiation at low cell density; with increased
cell density, the cell–cell contact force and interactions took priority over the matrix elasticity
[56]. Most notably, although cell differentiation was influenced by elastic modulus, recent
discovery found that matrix-promoted adipogenic or osteogenic differentiation could not
maintain when the cells were re-seeded into tissue culture plastic (TCP) [57]. Furthermore,
global gene expression profiles and DNA-methylation profiles revealed no significant impact
caused by matrix with different elasticity. These results indicated that matrix elasticity only
exerted a transient influence on stem cell lineage commitment.
3.2.2. Ligands and ligand densities
When cells were seeded on ECM with different ligand densities, changes in stem cell viability,
size, and shape provided the direct evidence that ligand immobilized to ECM could not be
easily separated from the biophysical effects of matrix [58,59]. The spatial arrangement of
ligands had a significant influence on MSC behavior [44]. Through manipulating of the ratio
of polystyrene-block-poly (ethylene oxide) copolymers (PS-PEO-Ma) in mixtures of block
copolymer and polystyrene homopolymer, the lateral spacing of RGD (arginine-glycine-
aspartic acid) peptides was under control. With increased lateral spacing, osteogenesis of MSC
was reduced while adipogenic differentiation was increased, which was consistent with the
results of gene expression levels and alkaline phosphatase activities.
Moreover, the type of ligands covalently linked to ECM could also influence stem cell fate
determination. The differentiation of MSCs on different composition of adhesion ligands with
the same concentration was various. MSCs cultured on fibronectin or laminin matrices tended
to undergo adipogenic differentiation; whereas, MSCs cultured on ECM containing collagen
preferred to adopt a neurogenic outcome [60].
3.2.3. Macro/nano-scale topography
Recent development also demonstrated that macro/nano-scale of ECM was another important
physical parameter that could not only change the shape of stem cells but also influence the
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behaviour of stem cells. A preliminary study demonstrated Zyxin played an important role in
nanotopographical feature-facilitated changes in stem cells [48]. On 350 nm grating, expression
of Zyxin was down-regulated, which was associated with the accelerated speed of migration
and the decreased intracellular tension. Likewise, McMurray et al. revealed that modification
in surface nanotopography of thermoplastic polycaprolactone (PCL) would influence intra‐
cellular tension, which could maintain the multipotency of stem cells and diminish spontane‐
ous differentiation of MSC [61]. Moreover, his current study further illustrated that nanoscale
spatial organization of cell-adhesive ligands bound to ECM could affect lineage commitment
of MSCs [62]. By using nanopatterning techniques, arginine-glycine-aspartate (RGD) was
covalently linked to the surface of poly (ethyleneglycol) (PEG) hydrogels with different
nanospacing. It was interesting to identify that large RGD nanospacing was beneficial for
osteogenesis; small RGD nanospacing was conducive to adipogenesis.
4. ECM augments therapeutic effects of stem cell therapy
Many attempts at cell therapy have employed ECM to improve efficacy for the following
reasons. First, the major obstacle to the application of stem cells, which is known as the
extremely poor survival and engraftment of transplanted stem cells, could be minimized by
co-transplantation stem cells with ECM [51,63,64]. Second, engineered ECM mimicking the
natural stem-cell microenvironments could provide plenty of subtle and instructive cues to
control the fate of both transplanted and endogenous cells, including stem cell self-renewal,
differentiation, and migration [7,65,66]. Taken together, the development of engineered
matrices is promising for the application of stem cells in regenerative medicine.
4.1. Enhance efficacy of transplanted cells
For both experimental studies and clinical applications, transplanted stem cells are commonly
prepared for transplantation as single cells. During this process, interactions between cells and
ECM are lost and adhesion-related survival signals are down-regulated, which could cause a
decrease in cell viability and initiated apoptosis [67]. Fortunately, recent research discovered
that the down-regulated molecules of detached cells could be regained in the presence of
Matrigel [4], which provided a theoretical rationale for using ECM as a protective scaffold to
enhance viability and to stimulate self-renewal of the transplanted cells.
In support of this finding, recent study demonstrated that biomimetic scaffold could protect
the transplanted stem cells, and further promote functional and structural recovery from acute
kidney injury (AKI). Through immobilization of the C-domain of insulin-like growth factor 1
(IGF-1C) to chitosan (CS) hydrogel (CS-IGF-1C), an artificial microenvironment for supporting
growth of stem cells was synthesized. The pro-proliferative, anti-apoptotic, and pro-angio‐
genic effects of CS-IGF-1C were demonstrably beneficial for enhancing survival of transplant‐
ed stem cells, which could ameliorate renal function [47] (Figure 5).
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Figure 5. CS-IGF-1C hydrogel increases ADSCs viability in vivo. (A) The fate of ADSCs after transplantation was
tracked by molecular imaging. Images are from representative animals receiving 1×106 ADSCs alone, with chitosan hy‐
drogel or CS-IGF-1C hydrogel. (B) Quantitative analysis of BLI signals demonstrated that cell survival was improved
by chitosan hydrogel and CS-IGF-1C hydrogel application at all time-points. CS-IGF-1C hydrogel group showed sig‐
nificantly better cell survival. Data are expressed as mean ± SEM. (C) Representative photomicrographs displayed the
engraftment of ADSCs (GFP, green) within kidneys at day 3 and 14. Proximal tubular epithelial cells were stained by
rhodamine-labeled lens culinaris agglutinin (LCA, red). (D) Quantitative analysis data revealed that chitosan hydrogel
improved cell engraftment and CS-IGF-1C hydrogel further increased this effect. Data are expressed as mean ± SEM.
*P<0.05 vs. ADSCs, #P<0.05 vs. ADSCs/CS. (E) Representative images showing the proliferation (Ki-67, red) of trans‐
planted ADSCs (GFP, green) in the border regions 3 days after AKI. DyLight 649-labeled LCA staining (cyan) was per‐
formed to reveal renal structure. (F) Quantification of the proliferation index of ADSCs. Data are expressed as mean ±
SEM. *P<0.05 vs. ADSCs, #P<0.05 vs. ADSCs/CS. (47). Reprinted by permission of the publisher.
Besides, we could attribute the efficacy of stem cell therapy partly to the pluripotency of stem
cells [68,69]. A morphological study of MSCs in collagen type I (Col I) hydrogel and in
interfacial polyelectrolyte complexation (IPC) based hydrogels containing Col I discovered
that cells were neatly arranged and closely packed in IPC- Col I hydrogel [70]. This uniform
arrangement results in notably enhanced commitment to the chondrogenic lineage of MSC,
which could be an attractive source of cartilage equivalents for tissue engineering.
Recently, a variety of studies have demonstrated that decellularized matrix could provide
tissue specific cues for cell growth and lineage commitment [71–73]. Decellularized myocardial
matrix hydrogel, which keeps the original structure and natural heart ECM, is the most
compelling example among these biomaterials. One of the most inspiring finding is that a
mouse heart could contract and beat again after removing its own cells and repopulating the
decellularized whole-heart ECMs (DC-ECMs) with multipotential cells that could differentiate
in response to the signals from the DC-ECMs. Through repopulating decellularized mouse
hearts with induced pluripotent stem cell (iPSC)-derived earliest heart progenitors, the
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recellularized DC-ECMs exhibited myocardium, vessel-like structures, intracellular Ca2+
transients (CaiT), spontaneous heart contractions and significant response to numerous drug
interventions [74].
4.2. Support the function of endogenous cells
MSCs could mobilize into circulating blood and be recruited to the injury site, which was
consistent with the evidence that numbers of MSCs were increased considerably in peripheral
blood [75]. Several approaches were used in an attempt to investigate this cell recruitment
event. It was unexpected to find that ECM was indispensable for the homing of MSCs toward
sites of injury [76]. The homing effect could be inhibited through adding inhibitor of serine
proteases and leupeptin to ECM, which illustrated the key role of matrix remodelling in MSC
migration. In addition, evidence also indicated that exposing MSCs to injury-associated ECM
prior to transplantation could augment the efficiency of MSCs’ intrinsic tropism for injury [77].
As resident stem cells and progenitor cells could be activated to participate tissue regeneration
after injury [78,79], ECM designed for cell seeding should also benefit the growth of host cells
and support the function of endogenous cells. Encouragingly, evidence suggested that host
cells could respond to ECM in the site of injury in vivo. Firstly, immune responses were elicited
in hosts, which was identified by the quickly infiltrated CD68+ cells throughout the entire ECM
within 3 days after implantation. Then there were indications of myogenesis in the muscle
injury area, which was confirmed by morphology and myosin heavy chain positive staining
[80].
Furthermore, accumulating data suggested that human mesenchymal stem cells (hMSCs)
could modulate immune system response through their paracrine effect and then create a
pro-regenerative environment in situ. Their paracrine effects could be optimized through
encapsulating hMSCs into protective ECM [81]. The recruitment of endogenous macrophag‐
es and the M1/M2 polarization were modulated by the trophic factors secreted by hMSCs,
which was possibly capable of counteracting the hostile environment and sustaining tissue
regeneration. This cell-friendly microenvironment could also be established by administra‐
tion of ECM alone. Increased stem cell tropism, revascularization, and improved cardiac
function induced by chitosan-based ECM were observed in ischemic myocardium [82],
which may be attributing to the mechanical support provided by ECM and the therapeutic
biomolecules enriched by ECM [83–85].
5. Future perspectives
The ECM is not only a simple scaffold that provides physical supports for stem cells but also
a dynamic and complex environment that is capable of regulating cell behaviours. Although
the application of natural or synthetic ECM with the aim to enhance therapeutic effects of stem
cells is highly appealing for promoting regenerative processes, issues related to efficiency and
safety limit their translational use as regenerative medicine. Further identifying specific
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biochemical and biophysical properties of ECM and understanding the interplay between stem
cells and ECM will provide knowledge of stem cell biology and fuel the development of
regenerative therapies based on stem cells.
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